Kocaeli Unıversity
Kocaeli, izmit, 41100, Turkey (Türkiye)
NCT Number: NCT06657092
Patients were randomized into two groups, ESP and control. Single-shot ultrasound (US)-guided ESP block with 20 ml 0.25% bupivacaine at the T4 vertebral level was performed preoperatively to all patients in the ESP group. The control group received no intervention. Patients in both groups were provided with intravenous patient-controlled analgesia device containing morphine for postoperative analgesia.
Looking for future studies?
Notify Me18 year–65 year
Female
Interventional
Not applicable
Kocaeli, izmit, 41100, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Single-shot ultrasound (US)-guided ESP block with 20 ml 0.25% bupivacaine ( Marcaine ) at the T4 vertebral level will be performed.
Other names: espb group
Postoperative 0.5 mg/kg morphine and 1 gr paracetamol will be admistered intravenously in the operation theatre and intravenous patient controlled analgesia (PCA) will be performed in the plastic surgery ward postoperatively
Time frame: Postoperative total opioid consumption in miligrams will be recorded at hour 24
Patients in both groups will receive opioid in postoperative period. Total opioid consumption in miligrams will be compared
Time frame: At the end of the operation
The amount of remifentanyl administered to patients via intravenous infusion during the operation in micrograms, will be recorded.
Gözde Gamze Uzun
Other
Ultrasound Guided Erector Spinae Plane Efficacy of Erector Spinae Plane Block for Analgesia in Breast Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05533099
Breast Diseases, Skin Diseases
Pisa, Italy
View Trial DetailsNCT03709446
Breast Diseases, Breast Neoplasms
New York, United States
View Trial DetailsNCT03730051
Breast Diseases, Skin Diseases
Worcester, Massachusetts, United States
View Trial DetailsNCT06187350
Artificial Intelligence, Breast Diseases
Linköping, Östergötland County, Sweden
View Trial Details